Risk Assessment Group

Monday, May 12

7:00 AM – 8:30 AM

Room: Imperial I (level IV)

Discussion Topic: Risk assessment at low doses: Discussion of new approaches.

Looking at the evidence: do we discard the old assumptions concerning linear dose-extrapolation at low doses? If so, how do we move forward?

Introductions, general overview of the Risk Assessment group activities, and input into the EMS Program for 2004

Ronald Snyder and Rosalie Elespuru

Brief, informal presentations by

Julian Preston (EPA)

Dale Walker (Lovelace Respiratory Research Institute)

Matt Bogdanfy (DuPont Haskell Lab) (invited)

Sheila Galloway (Merck)

Discussion during and after the presentations

Consideration of development of a position paper on low dose risk assessment from the EMS Risk Assessment Special Interest Group